Bangalore, India — Dassault Systèmes Pvt Ltd demonstrated innovations, focused on addressing challenges in the life sciences industry in India at the “The World After - From Things to Life” virtual event. Speakers from Biocon, IPCA, Skanray, Sahajanand Medical Technologies, Lupin, Agappe Diagnostics, Stryker, Brainsight, COMOFI Medtech, HCL Technologies and Jamia Milia Islamia University shared their knowledge and know-how, along with global and local life sciences industry experts and start-ups.
Tending to the business difficulties of the industry, the company showcased the "Permit to Cure for Biopharma," "ONE Lab," and "Quickened Device" industry solution experiences dependent on the 3DEXPERIENCE platform, a collaborative 3D virtual environment to envision sustainable innovations by creating virtual experience twins of the real world.
The pharma section of the event secured points like digital continuity in the pharmaceutical industry, revolutionizing the drug development process with artificial intelligence, design and development of SARS-CoV-2 primary protease inhibitors, streamlining laboratories and utilizing information to improve time to market. Ever-changing patient care section in the event discussed “In-Silico in healthcare,” optimizing efficacy and safety for medical devices, simulation-driven new product development (NPD), simulation for understanding the functional dynamics of the brain and therapeutic stimulations using AI. Lastly, the medical devices section in the event highlighted a faster time to market of innovative medical devices, and key technology solutions adopted in the diagnostics segment.
With a profound comprehension of the current difficulties, the company hosted the event as part of its commitment to help advance the pace of discovery of new drugs and medicines and deliver holistic, superior patient and physician-centric experiences.
Image Source: Dassault Systèmes